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     Outside the nasopharynx, undifferentiated carcinomas occur only rarely at other 
head and neck locations. Although the association between undifferentiated 
nasopharyngeal carcinoma and Epstein-Barr virus (EBV) is consistent, there is 
conflicting evidence as to the association of EBV with undifferentiated carcinomas 
outside the nasopharynx. Here, we report on a case of undifferentiated carcinoma of the 
tongue base. 
     A 71-year-old male, who had been treated with irradiation for primary unknown 
right neck metastatic EBV-positive undifferentiated carcinoma nine years previously, 
was referred to our clinic with masses at the tongue base and right neck. The lesion at 
the tongue base was revealed to be an EBV-positive undifferentiated carcinoma. He was 
treated with resection of tongue base tumor and bilateral-neck dissection, and the defect 
at the tongue base was reconstructed with a free rectus abdominis myocutaneous flap. 
Re-irradiation was added post-operatively because of a positive surgical margin at the 
tongue base. The patient is presently alive without recurrence or distant metastasis 20 
months after treatment. 
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     Although it is unclear whether our case is recurrent or newly developped 
EBV-latently infected undifferentiated carcinoma, we propose that EBV-associated 
tumors should be carefully observed after treatment at least for more than ten years.   
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INTRODUCTION 
     The consistent association of undifferentiated nasopharyngeal carcinoma with 
Epstein-Barr virus (EBV) has been based on serologic and immunologic data, as well as 
on the demonstration of viral antigens and viral DNA and/or RNA in the respective 
tumor cells [1]. Outside the nasopharynx, undifferentiated carcinomas occur only rarely 
at other head and neck locations, including the oropharynx, laryngo-hypopharynx and 
salivary gland [2, 3, 4, 5, 6]. Although morphologically similar, there is conflicting 
evidence as to the association of EBV with oropharyngeal undifferentiated carcinomas 
[7, 8]. 
     We describe the clinicopathological features of a case of undifferentiated 
carcinoma at the base of tongue with neck metastasis. Involvement of EBV in this case 
was demonstrated using in situ hybridization for EBV-encoded small RNAs (EBERs). 
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CASE REPORT 
     A 62-year-old male visited a previous clinic in December 1994 with a two-month 
history of a right neck mass. Physical examination on presentation revealed a fixed 
mass 3-cm in diameter at level III of the right neck. Direct laryngopharyngoscopy 
yielded unremarkable findings. The cervical lesion was biopsied and histological 
examination revealed metastatic EBERs-positive undifferentiated carcinoma (Fig.1A, 
B). Although the analysis of antibodies to the EBV capsid antigen (VCA) also revealed 
elevations of the Ig G and Ig A titers to 1:640 and 1:20, respectively, (normal is less than 
10, respectively), a biopsy from the nasopharynx didn’t show any malignant histology. 
Galium scanning did not show any potential pathological uptake indicating a primary 
tumor. The patient was treated with radiotherapy. The right side of the neck and the 
oropharynx received a total of 60 Gy, given at a dosage of 2 Gy daily. The 
naosopharynx was not involved in the irradiation field. Radical radiotherapy produced a 
good response, and the patient had shown no evidence of residual or recurrent disease 
for nine years. However, during follow-up, magnetic resonance imaging (MRI) revealed 
a tumor at the right side of the tongue base (Fig. 2A) and also the enlargement of a 
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lymph node at level IV of the right neck (Fig. 2B). Whole-body 
18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG-PET) 
exhibited a strongly positive 18F-FDG uptake in the right level IV lymph node and the 
right side of the base of the tongue, and also a weak uptake in the left cervical lymph 
nodes (Fig. 2C). 
     The patient was referred to our clinic (Fig. 3). VCA-Ig G and Ig A titers were 
1:160 and 1:20, respectively. The lesion at the tongue base was biopsied and 
histological examination revealed EBERs-positive undifferentiated carcinoma (Fig. 4A, 
B). The patient was surgically treated with resection of the tongue base tumor and 
bilateral neck dissection, and the defect at the tongue base was reconstructed with a free 
rectus abdominis myocutaneous flap. Histopathological examination revealed a positive 
surgical margin at the tongue base, and lymph nodes with metastatic carcinoma only at 
level IV of the right neck. Re-irradiation for the tongue base (20 Gy) and whole neck 
(40 Gy) was added post-operatively. After the completion of treatment, VCA-Ig G and 
Ig A titers were 1:160 and <1:10, respectively. The patient is presently alive without 
recurrence or distant metastasis 20 months after treatment (Fig. 5A, B). 
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DISCUSSION 
     Although undifferentiated carcinomas are common in the nasopharynx, reports of 
occurrences in the tonsil and tongue base are rare. Undifferentiated carcinomas have the 
same morphology as undifferentiated nasopharyngeal carcinomas, but their association 
with EBV appears to be influenced by the location of the tumor and geographical origin 
of the patients [9]. Although nineteen cases of undifferentiated carcinoma have been 
reported from the tonsil, base of the tongue, uvula, soft palate, and elsewhere in the oral 
cavity, the association of EBV with the development of oropharyngeal undifferentiated 
carcinomas has not been well elucidated [8]. However, our case was revealed to be 
EBV-positive because EBERs were clearly detected in the nucleus of tumor cells. 
Furthermore, after surgical resection of the tumor, the VCA-Ig A titer was decreased to 
an undetectable level. Although we need to collect evidence from a number of cases to 
show the possibility of the involvement of EBV in the pathogenesis of oropharyngeal 
undifferentiated carcinomas, this evidence indicates that EBV is involved in the 
pathogenesis of undifferentiated carcinomas in at least some oropharyngeal 
undifferentiated carcinoma cases.    
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     Maeda et al. reported that there was no case of oral squamous cell carcinoma 
(SCC) with poor differentiation in the EBV-negative group. EBV-DNA was detected in 
all six cases of poorly differentiated oral SCCs [10]. These results suggest that 
EBV-DNA replicates may be associated with the poor differentiation of squamous cell 
epithelium. However, Kobayashi et al. detected EBV-DNA in 7 out of 46 oral SCCs, 
and all seven positive samples were well-differentiated carcinoma, which suggested a 
possible relationship between EBV infection and well-differentiated carcinoma tissue 
[11]. Thus, it is not yet evident whether oropharyngeal carcinomas, especially at the 
level of differentiation, are EBV-associated. 
     Shimakage et al. reported that the incidence and intensity of fluorescence reacted 
on these EBV proteins were extremely high in samples from cases with poor prognosis, 
such as early recurrence, and that metastases exist according to the increase of EB viral 
protein synthesis [12]. However, Maeda et al. stated that EBV infection is not related to 
tumor response to radiotherapy, or the prognoses of the patients [10]. Horiuchi et al. 
also showed no correlation between the presence of EBV and the T-category, the 
incidence of lymph node metastasis, or the complete remission rate. There was also no 
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significant difference between the EBV-positive and EBV-negative patients with respect 
to their 5-year survival rates [10, 11]. Thus, the association between EBV and prognosis 
for these cancers remains unclear. 
     It seems reasonable to suppose that our case is a newly developed undifferentiated 
carcinoma at the tongue base, because nine years has passed since the primary therapy 
with irradiation. However, from the literature, the 10-year actuarial rate of mucosal 
carcinoma emergence is from 14 to 20 % after radiotherapy for patients with primary 
unknown cervical metastasis [13, 14]. In addition, metastatic lymph nodes were 
detected only at level IV of the right neck, which is not a physiological pattern of 
lymphatic spread of a newly developed tongue base carcinoma. Thus, it is also possible 
that our case is a recurrent tumor that emerged at the tongue base nine years after the 
initial treatment. Although a method to distinguish between a newly developed tumor 
and a recurrent tumor has not been established, checking the number of terminal repeats 
of a latently infected EBV genome should be a method of choice to determine the 
differences in the clonality of the EBV-positive tumor cells. Finally, we propose that 
EBV-associated tumors, including NPC, should be carefully followed up for longer 
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period, at least for more than ten years.                 
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FIGURE LEGENDS           
Fig. 1. A. Hematoxylin & eosin (HE) staining (original magnification x 200). Metastatic 
undifferentiated carcinoma of the right cervical lymphnode. The neoplastic cells are 
large-sized, with vesicular nucleoli, and indistinct cytoplasmic borders. B. RNA in situ 
hybridization using an EBERs probe, counter stained with methylgreen (original 
magnification x 200). Positive signals are seen in the nuclei of almost all of the cancer 
cells. 
 
Fig. 2. A. An axial gadolinium enhanced T1-weighted MRI image showing a 
homgenously enhanced ulcerated mass involving the right side and beyond the midline 
of the tongue base (Arrow). B. A coronal gadolinium enhanced T1-weighted MRI image 
demonstrates an enlargement of the right level IV lymph node (Arrow). C. Positive 
focal uptake in the tongue base and the right level IV lymph node on PET. Weak 
uptakes in the left cervical lymph nodes were also exhibited.  
 
Fig. 3. Endoscopic view of the tumor of the tongue base before treatment (Arrowheads 
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demonstrate the extent of the tumor). The surface of the lesion is ulcerative. Biopsy of 
the lesion revealed undifferentiated carcinoma. Arrow: epiglottis. 
 
Fig. 4. A. HE staining (original magnification x 200).  Undifferentiated carcinoma of 
the tongue base showing the proliferation of tumor cells with marked lymphocyte 
infiltrates. The tumor cells are medium sized, with prominent nucleoli, and indistinct 
cytoplasmic borders. B. RNA in situ hybridization using an EBERs probe, not counter 
stained (original magnification x 200). Positive signals are seen in the nuclei of almost 
all of the cancer cells.  
 
Fig. 5. A. Postoperative endoscopic view of the oropharynx. Arrowheads indicate the 
free rectus abdominis myocutaneous flap, which fills the defect after surgical resection 
of the tumor of the tongue base. Arrow: uvula. B. Postoperative CT at 20 months after 
surgery. Arrowheads demonstrate the extent of the myocutaneous flap. The patient is 
currently alive without locoregional reccurrence or distant metastasis.    
